General information about company · 2020. 7. 20. · General information about company Scrip code...

22
7/20/2020 REport_OPL_JUne_2020.html file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 1/22 General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM LIMITED Whether company is SME No Class of Security Equity Shares Type of report Quarterly Quarter Ended / Half year ended/Date of Report (For Prelisting / Allotment) 30-06-2020 Date of allotment / extinguishment (in case Capital Restructuring selected) / Listing Date Shareholding pattern filed under Regulation 31 (1) (b)

Transcript of General information about company · 2020. 7. 20. · General information about company Scrip code...

Page 1: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 1/22

General information about company

Scrip code 532167

NSE Symbol

MSEI Symbol

ISIN INE501C01015

Name of the company OMKAR PHARMACHEM LIMITED

Whether company is SME No

Class of Security Equity Shares

Type of report Quarterly

Quarter Ended / Half year ended/Date of Report (For Prelisting / Allotment) 30-06-2020

Date of allotment / extinguishment (in case Capital Restructuring selected) / Listing Date

Shareholding pattern filed under Regulation 31 (1) (b)

Page 2: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 2/22

Declaration

Sr.No. Particular Yes/No Promoter and

Promoter GroupPublic

shareholderNon Promoter-

Non Public

1 Whether the Listed Entity has issued any partly paid up shares? Yes No Yes No

2 Whether the Listed Entity has issued any Convertible Securities? No No No No

3 Whether the Listed Entity has issued any Warrants ? No No No No

4 Whether the Listed Entity has any shares against whichdepository receipts are issued? No No No No

5 Whether the Listed Entity has any shares in locked-in? No No No No

6 Whether any shares held by promoters are pledge or otherwiseencumbered? No No

7 Whether company has equity shares with differential votingrights? No No No No

8 Whether the listed entity has any significant beneficial owner? No

Page 3: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 3/22

Table I - Summary Statement holding of specified securities

Category(I)

Categoryofshareholder(II)

Nos. Ofshareholders(III)

No. offully paidup equitysharesheld (IV)

No. OfPartlypaid-upequitysharesheld(V)

No. OfsharesunderlyingDepositoryReceipts(VI)

Total nos.sharesheld (VII)= (IV)+(V)+ (VI)

Shareholding as a% of total no. ofshares (calculatedas per SCRR,1957) (VIII) As a% of (A+B+C2)

Number of Voting Rights held in eachclass of securities (IX)

No of Voting (XIV) Rights Total as a% of(A+B+C)Class eg:

XClasseg:y Total

(A)

Promoter&PromoterGroup

2 2600 2600 0.03 2600 2600 0.03

(B) Public 3516 10080700 1500 10082200 99.97 10082200 10082200 99.97

(C)NonPromoter-Non Public

(C1)SharesunderlyingDRs

(C2)

Shares heldbyEmployeeTrusts

Total 3518 10083300 1500 10084800 100 10084800 10084800 100

Page 4: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 4/22

Table I - Summary Statement holding of specified securities

Category(I)

Categoryofshareholder(II)

No. OfSharesUnderlyingOutstandingconvertiblesecurities(X)

No. ofSharesUnderlyingOutstandingWarrants(Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities andNo. OfWarrants (Xi)(a)

Shareholding , as a %assuming fullconversion ofconvertible securities (as a percentage ofdiluted share capital)(XI)= (VII)+(X) As a %of (A+B+C2)

Number ofLocked inshares (XII)

Number ofSharespledged orotherwiseencumbered(XIII)

Number ofequity sharesheld indematerializedform (XIV)

No.(a)

As a% oftotalSharesheld(b)

No.(a)

As a% oftotalSharesheld(b)

(A)

Promoter&PromoterGroup

0.03 0

(B) Public 99.97 4925300

(C)NonPromoter-Non Public

(C1)SharesunderlyingDRs

(C2)

Shares heldbyEmployeeTrusts

Total 100 4925300

Page 5: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 5/22

Table II - Statement showing shareholding pattern of the Promoter and Promoter Group

Sr.Category &Name of theShareholders (I)

Nos. Ofshareholders(III)

No. offully paidup equitysharesheld (IV)

No.OfPartlypaid-upequitysharesheld(V)

No. OfsharesunderlyingDepositoryReceipts(VI)

Total nos.sharesheld(VII) =(IV)+(V)+ (VI)

Shareholdingas a % oftotal no. ofshares(calculated asper SCRR,1957) (VIII)As a % of(A+B+C2)

Number of Voting Rights held in eachclass of securities (IX)

No of Voting (XIV) Rights Totalas a %ofTotalVotingrights

Class eg:X

Classeg:y Total

A Table II - Statement showing shareholding pattern of the Promoter and Promoter Group

(1) Indian

(a) Individuals/Hinduundivided Family 2 2600 2600 0.03 2600 2600 0.03

Sub-Total(A)(1) 2 2600 2600 0.03 2600 2600 0.03

(2) Foreign

TotalShareholdingof PromoterandPromoterGroup (A)=(A)(1)+(A)(2)

2 2600 2600 0.03 2600 2600 0.03

B Table III - Statement showing shareholding pattern of the Public shareholder

(1) Institutions

( 3 ) Non-institutions

(a(i))

Individuals -i.Individualshareholdersholding nominalshare capital upto Rs. 2 lakhs.

3394 1160662 1500 1162162 11.52 1162162 1162162 11.52

(a(ii))

Individuals - ii.Individualshareholdersholding nominalshare capital inexcess of Rs. 2lakhs.

114 8756170 0 8756170 86.83 8756170 8756170 86.83

(e) Any Other(specify) 8 163868 0 163868 1.62 163868 163868 1.62

Sub-Total(B)(3) 3516 10080700 1500 10082200 99.97 10082200 10082200 99.97

Total PublicShareholding(B)=(B)(1)+(B)(2)+(B)(3)

3516 10080700 1500 10082200 99.97 10082200 10082200 99.97

C Table IV - Statement showing shareholding pattern of the Non Promoter- Non Public shareholder

Total (A+B+C2 ) 3518 10083300 1500 10084800 100 10084800 10084800 100

Total(A+B+C ) 3518 10083300 1500 10084800 100 10084800 10084800 100

Page 6: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 6/22

Table II - Statement showing shareholding pattern of the Promoter and Promoter Group

Sr.

No. OfSharesUnderlyingOutstandingconvertiblesecurities(X)

No. ofSharesUnderlyingOutstandingWarrants(Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities andNo. OfWarrants (Xi)(a)

Shareholding , as a %assuming fullconversion ofconvertible securities (as a percentage ofdiluted share capital)(XI)= (VII)+(X) As a% of (A+B+C2)

Number ofLocked inshares (XII)

Number of Sharespledged orotherwiseencumbered (XIII) Number of

equity sharesheld indematerializedform (XIV)No.

(a)

As a% oftotalSharesheld(b)

No.(a)

As a % of totalShares held(b)

A Table II - Statement showing shareholding pattern of the Promoter and Promoter Group

(1) Indian

(a) 0.03 0

Sub-Total (A)(1) 0.03 0

(2) Foreign

TotalShareholdingof Promoterand PromoterGroup (A)=(A)(1)+(A)(2)

0.03 0

B Table III - Statement showing shareholding pattern of the Public shareholder

(1) Institutions

( 3 ) Non-institutions

(a(i)) 11.52 158662

(a(ii)) 86.83 4608870

(e) 1.62 157768

Sub-Total (B)(3) 99.97 4925300

Total PublicShareholding(B)=(B)(1)+(B)(2)+(B)(3)

99.97 4925300

C Table IV - Statement showing shareholding pattern of the Non Promoter- Non Public shareholder

Total (A+B+C2 ) 100 4925300

Total(A+B+C ) 100 4925300

Disclosure of notes on shareholding pattern TextualInformation(1)

Disclosure of notes in case of promoter holiding in dematerialsed form is less than 100 percentage TextualInformation(1)

Page 7: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 7/22

Text Block

Textual Information()

Dear Sir, This is with reference to PAN details of Some of the Shareholders in the Public ShareholdingCategory (under individual shareholders holding nominal share capital in excess of Rs 2 Lakhs), has notbeen mentioned in this Shareholding Pattern. Here, in continuation of the aforesaid matter, we would liketo bring to your kind notice that the company has tried to reach out to its shareholders and have also sentthem request letters and thereby requesting them to provide and update their PAN details with thecompany/RTA/Depository NSDL & CDSL, vide letter dated 13th May 2017 and followed by a reminderLetters dated 24th May 2017 and 16th May 2018, to all those shareholders whose PAN details are notavailable with the Company/RTA. However, till date neither we, nor the RTA/CDSL/NSDL has receivedany intimation from them. Further, We would also like to inform you that as per SEBI Circular dated20th April 2018, we have sent request letters through RTA dated 27th June 2018 and followed by 1stReminder dated 11th September 2018 and 2nd Reminder Dated 18th October 2018 to all theshareholders holding shares in physical form (including these seven public shareholders) to provide theirPAN and Account details and also requested them to convert their physical shareholding into dematform. Thus, in view of the facts mentioned supra, we request you to kindly consider the Shareholdingpattern filed for the Quarter ended on 30th June 2020 or any other filed on or before such date or to befiled in future, as valid, as despite of making reasonable efforts to reach out to our shareholders thecompany is unable to retrieve the requisite information from them i.e receiving their PAN details. Lastly,we do hereby declare that as soon as we will receive the PAN details from those shareholders we willupdate the same in the format required to be filed with stock exchange on quarterly basis. We hope youwill consider our request.

Textual Information() Dematerialisation of Shares of Promoter and Promoter Group is in Process

Page 8: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 8/22

Individuals/Hindu undivided Family

Searial No. 1 2 3 4 5 6 7

Name of theShareholders(I)

SHAHKIRTIKUMARLAXMICHAND

DIPAKKUMARMULCHANDBHAIVORA

ASHOKMULCHANDBHAIVOHRA

ASHOKMULCHANDBHAIVORA HUF

KAUSHIKMULCHANDBHAIVORA HUF

KAUSHIKBHAIMULCHANDBHAIVORA

NIRMALABENASHOKBHAI

PAN (II) AAEPS3593G AAKPV7919B AAIPV4125D AAPHA8720E AADHK7597R AAJPV5225D ABTPV1482H

No. of fullypaid up equityshares held(IV)

1800 800 0 0 0 0 0

No. Of Partlypaid-up equityshares held(V)

No. Of sharesunderlyingDepositoryReceipts (VI)

Total nos.shares held(VII) = (IV)+(V)+ (VI)

1800 800 0 0 0 0 0

Shareholdingas a % of totalno. of shares(calculated asper SCRR,1957) (VIII)As a % of(A+B+C2)

0.02 0.01 0 0 0 0 0

Number of Voting Rights held in each class of securities (IX)

Class eg:X 1800 800 0 0 0 0 0

Class eg:y

Total 1800 800 0 0 0 0 0

Total as a %of TotalVoting rights

0.02 0.01 0 0 0 0 0

No. Of SharesUnderlyingOutstandingconvertiblesecurities (X)

No. of SharesUnderlyingOutstandingWarrants (Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities andNo. OfWarrants (Xi)(a)

Shareholding ,as a %assuming fullconversion ofconvertiblesecurities (as apercentage ofdiluted sharecapital) (XI)=(VII)+(Xi)(a)As a % of(A+B+C2)

0.02 0.01 0 0 0 0 0

Number of Locked in shares (XII)

No. (a)

As a % oftotal Sharesheld (b)

Page 9: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 9/22

Number of Shares pledged or otherwise encumbered (XIII)

No. (a)

As a % oftotal Sharesheld (b)

Number ofequity sharesheld indematerializedform (XIV)

0 0 0 0 0 0 0

Reason for not providing PAN

Reason for notprovidingPAN

Shareholdertype Promoter Promoter Promoter Group Promoter Group Promoter Group Promoter Group Promoter Group

Page 10: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 10/22

Individuals/Hindu undivided Family

Searial No. 8 9 10 11 12 13

Name of theShareholders (I)

PANKAJBHAIMULCHANDBHAIVORA

SHAH AJITLAXMICHAND

SHAHJAYSHREEAJIT

SHAHKAUSHIKRATILAL-B

SHAHNAYANAKAUSHIK

VAISHALIKAUSHIKBHAI

PAN (II) ABUPV0580H AMTPS5397M AWRPS4216M AMVPS8330G BLHPS7937P ABTPV1484B

No. of fully paidup equity sharesheld (IV)

0 0 0 0 0 0

No. Of Partly paid-up equity sharesheld (V)

No. Of sharesunderlyingDepositoryReceipts (VI)

Total nos. sharesheld (VII) = (IV)+(V)+ (VI)

0 0 0 0 0 0

Shareholding as a% of total no. ofshares (calculatedas per SCRR,1957) (VIII) As a% of (A+B+C2)

0 0 0 0 0 0

Number of Voting Rights held in each class of securities (IX)

Class eg:X 0 0 0 0 0 0

Class eg:y

Total 0 0 0 0 0 0

Total as a % ofTotal Voting rights 0 0 0 0 0 0

No. Of SharesUnderlyingOutstandingconvertiblesecurities (X)

No. of SharesUnderlyingOutstandingWarrants (Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities and No.Of Warrants (Xi)(a)

Shareholding , as a% assuming fullconversion ofconvertiblesecurities (as apercentage ofdiluted sharecapital) (XI)=(VII)+(Xi)(a) As a% of (A+B+C2)

0 0 0 0 0 0

Number of Locked in shares (XII)

No. (a)

As a % of totalShares held (b)

Number of Shares pledged or otherwise encumbered (XIII)

No. (a)

As a % of totalShares held (b)

Number of equityshares held indematerializedform (XIV)

0 0 0 0 0 0

Page 11: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 11/22

Reason for not providing PAN

Reason for notproviding PAN

Shareholder type Promoter Group Promoter Group PromoterGroup Promoter Group Promoter Group Promoter Group

Page 12: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 12/22

Individuals/Hindu undivided Family

Searial No.

Name of theShareholders (I) Click here to go back

PAN (II) Total

No. of fully paidup equity sharesheld (IV)

2600

No. Of Partly paid-up equity sharesheld (V)

No. Of sharesunderlyingDepositoryReceipts (VI)

Total nos. sharesheld (VII) = (IV)+(V)+ (VI)

2600

Shareholding as a% of total no. ofshares (calculatedas per SCRR,1957) (VIII) As a% of (A+B+C2)

0.03

Number of Voting Rights held in each class of securities (IX)

Class eg:X 2600

Class eg:y

Total 2600

Total as a % ofTotal Voting rights 0.03

No. Of SharesUnderlyingOutstandingconvertiblesecurities (X)

No. of SharesUnderlyingOutstandingWarrants (Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities and No.Of Warrants (Xi)(a)

Shareholding , as a% assuming fullconversion ofconvertiblesecurities (as apercentage ofdiluted sharecapital) (XI)=(VII)+(Xi)(a) As a% of (A+B+C2)

0.03

Number of Locked in shares (XII)

No. (a)

As a % of totalShares held (b)

Number of Shares pledged or otherwise encumbered (XIII)

No. (a)

As a % of totalShares held (b)

Number of equityshares held indematerializedform (XIV)

0

Reason for not providing PAN

Page 13: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 13/22

Reason for notproviding PAN

Shareholder type

Page 14: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 14/22

Individuals - ii. Individual shareholders holding nominal share capital in excess of Rs. 2 lakhs.

Searial No. 1 2 3 4 5 6 7

Name of theShareholders (I)

ASHOKKUMARBHATIA

BHANSINGH

HARVINDERSINGHCHADHA

KIMATIKUMARSINGH

RADHESHYAMYADAV

RESAMSINGH

ROSHANLAL

PAN (II) ALVPK5614Q

No. of fully paidup equity sharesheld (IV)

150000 375000 112500 129700 175000 250000 112300

No. Of Partly paid-up equity sharesheld (V)

0 0 0 0 0 0 0

No. Of sharesunderlyingDepositoryReceipts (VI)

Total nos. sharesheld (VII) = (IV)+(V)+ (VI)

150000 375000 112500 129700 175000 250000 112300

Shareholding as a% of total no. ofshares (calculatedas per SCRR,1957) (VIII) As a% of (A+B+C2)

1.49 3.72 1.12 1.29 1.74 2.48 1.11

Number of Voting Rights held in each class of securities (IX)

Class eg: X 150000 375000 112500 129700 175000 250000 112300

Class eg:y

Total 150000 375000 112500 129700 175000 250000 112300

Total as a % ofTotal Voting rights 1.49 3.72 1.12 1.29 1.74 2.48 1.11

No. Of SharesUnderlyingOutstandingconvertiblesecurities (X)

No. of SharesUnderlyingOutstandingWarrants (Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities and No.Of Warrants (Xi)(a)

Shareholding , as a% assuming fullconversion ofconvertiblesecurities (as apercentage ofdiluted sharecapital) (XI)=(VII)+(X) As a %of (A+B+C2)

1.49 3.72 1.12 1.29 1.74 2.48 1.11

Number of Locked in shares (XII)

No. (a)

As a % of totalShares held (b)

Number of equityshares held indematerializedform (XIV)

0 0 0 129700 0 0 0

Reason for not providing PAN

Reason for notproviding PAN

TextualInformation(1)

TextualInformation(2)

TextualInformation(3)

TextualInformation(4)

TextualInformation(5)

TextualInformation(6)

Page 15: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 15/22

Individuals - ii. Individual shareholders holding nominal share capital in excess of Rs. 2 lakhs.

Searial No. 8 9 10 11 12 13 14

Name of theShareholders (I)

SUKHDEVSINGH

CHANDRAPAL YADAV

SHILENDRAYADAV

ASHOKKUMARTIWARI

MANMEETCHADHA

RUPESHCHAUHAN

LAIQUAHMEDANSARI

PAN (II) ASXPS6639Q AAVPY8467A ABAPY2157R ACXPT7381G ADAPC4396G AEVPC0171K AFUPA1256R

No. of fully paidup equity sharesheld (IV)

112500 160000 165000 165000 157500 160000 150470

No. Of Partly paid-up equity sharesheld (V)

0 0 0 0 0 0 0

No. Of sharesunderlyingDepositoryReceipts (VI)

Total nos. sharesheld (VII) = (IV)+(V)+ (VI)

112500 160000 165000 165000 157500 160000 150470

Shareholding as a% of total no. ofshares (calculatedas per SCRR,1957) (VIII) As a% of (A+B+C2)

1.12 1.59 1.64 1.64 1.56 1.59 1.49

Number of Voting Rights held in each class of securities (IX)

Class eg: X 112500 160000 165000 165000 157500 160000 150470

Class eg:y

Total 112500 160000 165000 165000 157500 160000 150470

Total as a % ofTotal Voting rights 1.12 1.59 1.64 1.64 1.56 1.59 1.49

No. Of SharesUnderlyingOutstandingconvertiblesecurities (X)

No. of SharesUnderlyingOutstandingWarrants (Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities and No.Of Warrants (Xi)(a)

Shareholding , as a% assuming fullconversion ofconvertiblesecurities (as apercentage ofdiluted sharecapital) (XI)=(VII)+(X) As a %of (A+B+C2)

1.12 1.59 1.64 1.64 1.56 1.59 1.49

Number of Locked in shares (XII)

No. (a)

As a % of totalShares held (b)

Number of equityshares held indematerializedform (XIV)

0 160000 165000 165000 157500 160000 150470

Reason for not providing PAN

Reason for notproviding PAN

Page 16: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 16/22

Individuals - ii. Individual shareholders holding nominal share capital in excess of Rs. 2 lakhs.

Searial No. 15 16 17 18 19 20 21

Name of theShareholders (I)

AHSAN ALIKHAN

MANOJKUMAR SINGH

JASPALSINGH

ANANDSHARMA

VIJAYSHARMA

KAILASHNATH SINGH

RAJEEVKUMARSAXENA

PAN (II) ALVPK5615R ANIPS4098K ASCPS0289H ASCPS0290A ASCPS7212A ASVPS0822P ASVPS0826K

No. of fully paidup equity sharesheld (IV)

185000 177500 112500 155000 141500 150000 141000

No. Of Partly paid-up equity sharesheld (V)

0 0 0 0 0 0 0

No. Of sharesunderlyingDepositoryReceipts (VI)

Total nos. sharesheld (VII) = (IV)+(V)+ (VI)

185000 177500 112500 155000 141500 150000 141000

Shareholding as a% of total no. ofshares (calculatedas per SCRR,1957) (VIII) As a% of (A+B+C2)

1.83 1.76 1.12 1.54 1.4 1.49 1.4

Number of Voting Rights held in each class of securities (IX)

Class eg: X 185000 177500 112500 155000 141500 150000 141000

Class eg:y

Total 185000 177500 112500 155000 141500 150000 141000

Total as a % ofTotal Voting rights 1.83 1.76 1.12 1.54 1.4 1.49 1.4

No. Of SharesUnderlyingOutstandingconvertiblesecurities (X)

No. of SharesUnderlyingOutstandingWarrants (Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities and No.Of Warrants (Xi)(a)

Shareholding , as a% assuming fullconversion ofconvertiblesecurities (as apercentage ofdiluted sharecapital) (XI)=(VII)+(X) As a %of (A+B+C2)

1.83 1.76 1.12 1.54 1.4 1.49 1.4

Number of Locked in shares (XII)

No. (a)

As a % of totalShares held (b)

Number of equityshares held indematerializedform (XIV)

120000 177500 112500 155000 141500 150000 141000

Reason for not providing PAN

Reason for notproviding PAN

Page 17: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 17/22

Individuals - ii. Individual shareholders holding nominal share capital in excess of Rs. 2 lakhs.

Searial No. 22 23 24 25 26 27 28

Name of theShareholders (I)

HAR KISHANSINGH

SHAILESHSHARMA

AKSHAYSAXENA

JITENDERSINGH

SANJEEVSAXENA

RAGHUVEERSINGH

BHAGSINGH

PAN (II) ASVPS0827J ASVPS0830P GPWPS1682K AVXPS8715Q AWGPS5129J AWGPS5130D BCCPS9744Q

No. of fully paidup equity sharesheld (IV)

130500 142500 200000 175000 155000 164600 250000

No. Of Partly paid-up equity sharesheld (V)

0 0 0 0 0 0 0

No. Of sharesunderlyingDepositoryReceipts (VI)

Total nos. sharesheld (VII) = (IV)+(V)+ (VI)

130500 142500 200000 175000 155000 164600 250000

Shareholding as a% of total no. ofshares (calculatedas per SCRR,1957) (VIII) As a% of (A+B+C2)

1.29 1.41 1.98 1.74 1.54 1.63 2.48

Number of Voting Rights held in each class of securities (IX)

Class eg: X 130500 142500 200000 175000 155000 164600 250000

Class eg:y

Total 130500 142500 200000 175000 155000 164600 250000

Total as a % ofTotal Voting rights 1.29 1.41 1.98 1.74 1.54 1.63 2.48

No. Of SharesUnderlyingOutstandingconvertiblesecurities (X)

No. of SharesUnderlyingOutstandingWarrants (Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities and No.Of Warrants (Xi)(a)

Shareholding , as a% assuming fullconversion ofconvertiblesecurities (as apercentage ofdiluted sharecapital) (XI)=(VII)+(X) As a %of (A+B+C2)

1.29 1.41 1.98 1.74 1.54 1.63 2.48

Number of Locked in shares (XII)

No. (a)

As a % of totalShares held (b)

Number of equityshares held indematerializedform (XIV)

130500 142500 200000 175000 155000 164600 250000

Reason for not providing PAN

Reason for notproviding PAN

Page 18: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 18/22

Individuals - ii. Individual shareholders holding nominal share capital in excess of Rs. 2 lakhs.

Searial No. 29

Name of theShareholders (I) JAGDISH CHAND BHATIA Click here to go back

PAN (II) Total

No. of fully paidup equity sharesheld (IV)

130000 4785070

No. Of Partly paid-up equity sharesheld (V)

0 0

No. Of sharesunderlyingDepositoryReceipts (VI)

Total nos. sharesheld (VII) = (IV)+(V)+ (VI)

130000 4785070

Shareholding as a% of total no. ofshares (calculatedas per SCRR,1957) (VIII) As a% of (A+B+C2)

1.29 47.45

Number of Voting Rights held in each class of securities (IX)

Class eg: X 130000 4785070

Class eg:y

Total 130000 4785070

Total as a % ofTotal Voting rights 1.29 47.45

No. Of SharesUnderlyingOutstandingconvertiblesecurities (X)

No. of SharesUnderlyingOutstandingWarrants (Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities and No.Of Warrants (Xi)(a)

Shareholding , as a% assuming fullconversion ofconvertiblesecurities (as apercentage ofdiluted sharecapital) (XI)=(VII)+(X) As a %of (A+B+C2)

1.29 47.45

Number of Locked in shares (XII)

No. (a)

As a % of totalShares held (b)

Number of equityshares held indematerializedform (XIV)

0 3302770

Reason for not providing PAN

Reason for notproviding PAN Textual Information(7)

Page 19: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 19/22

Text Block

Textual Information(1) PAN Number not provided by the shareholder

Textual Information(2) PAN Number not provided by the shareholder

Textual Information(3) PAN Number not provided by the shareholder

Textual Information(4) PAN Number not provided by the shareholder

Textual Information(5) PAN Number not provided by the shareholder

Textual Information(6) PAN Number not provided by the shareholder

Textual Information(7) PAN Number not provided by the shareholder

Page 20: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 20/22

Any Other (specify)

Searial No. 1

Category Bodies Corporate

Category / Morethan 1 percentage More than 1 percentage of shareholding

Name of theShareholders (I) GUJARAT STATE FINANCIAL CORPORATION Click here to go back

PAN (II) AABCG2924M Total

No. of theShareholders (I) 1 0

No. of fully paidup equity sharesheld (IV)

150000 0

No. Of Partly paid-up equity sharesheld (V)

0 0

No. Of sharesunderlyingDepositoryReceipts (VI)

Total nos. sharesheld (VII) = (IV)+(V)+ (VI)

150000 0

Shareholding as a% of total no. ofshares (calculatedas per SCRR,1957) (VIII) As a% of (A+B+C2)

1.49 0

Number of Voting Rights held in each class of securities (IX)

Class eg: X 150000 0

Class eg:y

Total 150000 0

Total as a % ofTotal Voting rights 1.49 0

No. Of SharesUnderlyingOutstandingconvertiblesecurities (X)

No. of SharesUnderlyingOutstandingWarrants (Xi)

No. Of SharesUnderlyingOutstandingconvertiblesecurities and No.Of Warrants (Xi)(a)

Shareholding , as a% assuming fullconversion ofconvertiblesecurities (as apercentage ofdiluted sharecapital) (XI)=(VII)+(X) As a %of (A+B+C2)

1.49 0

Number of Locked in shares (XII)

No. (a)

As a % of totalShares held (b)

Number of equityshares held indematerializedform (XIV)

150000 0

Page 21: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 21/22

Reason for not providing PAN

Reason for notproviding PAN

Page 22: General information about company · 2020. 7. 20. · General information about company Scrip code 532167 NSE Symbol MSEI Symbol ISIN INE501C01015 Name of the company OMKAR PHARMACHEM

7/20/2020 REport_OPL_JUne_2020.html

file:///C:/Users/Dell/Desktop/REport_OPL_JUne_2020.html 22/22

Sr. No.Details of the SBODetails of the registered ownerDetails of holding/ exercise of right of the SBO in the reporting company, whether direct orindirect*:Date of creation / acquisition of significant beneficial interestNamePAN Passport No. in case of a foreign nationalNationalityNationality

(Applicable in case of Any other is selected)NamePAN Passport No. in case of a foreign nationalNationalityNationality (Applicable in case of Any other isselected)Whether by virtue of:SharesVoting rightsRights on distributable dividend or any other distributionExercise of controlExercise of significant

influence